[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Cazacu et al., 2020 - Google Patents

Quality of life impact of EUS in patients at risk for developing pancreatic cancer

Cazacu et al., 2020

View HTML
Document ID
17392800083827363920
Author
Cazacu I
Chavez A
Mendoza T
Qiao W
Singh B
Bokhari R
Saftoiu A
Lee J
Weston B
Stroehlein J
Kim M
Katz M
Maitra A
McAllister F
Bhutani M
Publication year
Publication venue
Endoscopic Ultrasound

External Links

Snippet

Methods: Eighty patients with PCL and/or increased genetic or familial risk for PC who had undergone EUS were contacted. Fifty percent of those patients successfully completed the brief profile of mood states (POMS) and the linear analog scale assessment (LASA) QOL …
Continue reading at journals.lww.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345Medical expert systems, neural networks or other automated diagnosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Similar Documents

Publication Publication Date Title
Marchegiani et al. “Trivial” cysts redefine the risk of cancer in presumed branch-duct intraductal papillary mucinous neoplasms of the pancreas: a potential target for follow-up discontinuation?
Oba et al. Prognosis based definition of resectability in pancreatic cancer: a road map to new guidelines
Segev et al. Left-sided dominance of early-onset colorectal cancers: a rationale for screening flexible sigmoidoscopy in the young
Adaway et al. Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement
Jurga-Karwacka et al. A forgotten disease: Pelvic congestion syndrome as a cause of chronic lower abdominal pain
Mosk et al. Low skeletal muscle mass as a risk factor for postoperative delirium in elderly patients undergoing colorectal cancer surgery
Miao Jonasson et al. HbA1C and cancer risk in patients with type 2 diabetes–a nationwide population-based prospective cohort study in Sweden
Pearce et al. A longitudinal study of predictors of sexual dysfunction in men on active surveillance for prostate cancer
Cazacu et al. Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review
Zhi et al. Low skeletal muscle area as a prognostic marker for chronic obstructive pulmonary disease in elderly patients admitted to ICU
Cazacu et al. Quality of life impact of EUS in patients at risk for developing pancreatic cancer
Fastrez et al. Evaluation of 18FDG PET-CT in the diagnosis of endometriosis: a prospective study
Marchegiani et al. Serous cystic neoplasms of the pancreas management in the real-world: still operating on a benign entity
Cavaliere et al. 1st evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer
Carter et al. The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy
Chen et al. Analyses of high-risk factors for cervical lymph node metastasis in laryngeal squamous cell carcinoma and establishment of nomogram prediction model
Zheng et al. Combining contrast-enhanced ultrasound and blood cell analysis to improve diagnostic accuracy of plasma cell mastitis
Meng et al. Mesenteric abnormalities play an important role in grading intestinal fibrosis in patients with Crohn’s disease: a computed tomography and clinical marker-based nomogram
Ecker et al. Segmental versus diffuse main duct intraductal papillary mucinous neoplasm: Examination of main pancreatic duct morphology and implications for malignancy risk and extent of surgical resection
Karamanos et al. The relationship between age, common bile duct diameter and diagnostic probability in suspected choledocholithiasis
Armstrong et al. Risk factors for progression in patients undergoing surveillance for pancreatic cysts
Schweighauser et al. Evaluation of endosonography as a new diagnostic tool for feline pancreatitis
Loh et al. A novel CT-emphysema index/FEV1 approach of phenotyping COPD to predict mortality
Miniati et al. Body height as risk factor for emphysema in COPD
Goksever Celik et al. Abdominal wall endometriosis: A monocentric continuous series and review of the literature